Peritoneal Fibrosis and High Transport Are Induced in Mildly Pre-injured Peritoneum by 3,4-Dideoxyglucosone-3-ene in Mice

Peritoneal dialysis (PD) solution contains high concentrations of glucose and glucose degradation products (GDPs). One of several GDPs—3,4-dideoxyglucosone-3-ene (3,4-DGE)—was recently identified as the most reactive and toxic GDP in PD fluids. In vitro, 3,4-DGE has been shown to induce mesothelial cell damage; however, its role in peritoneal fibrosis in vivo remains unclear. In the present study, we intraperitoneally administered chlorhexidine gluconate (CG) for mild peritoneal injury, and we then injected 3,4-DGE [38 μmol/L (low concentration) or 145 μmol/L (high concentration)] 5 times weekly for 4 weeks. Significant thickening of the parietal peritoneal membrane was observed only when treatment with low or high concentrations of 3,4-DGE occurred after CG administration, but not when either CG or 3,4-DGE alone was given. The combination of CG and 3,4-DGE also caused upregulation of messenger RNA expression of transforming growth factor β1, connective tissue growth factor, fibronectin, collagen type 1 α1 chain, alpha smooth muscle actin (α-SMA), vascular endothelial growth factor 164, NADPH oxidase 1 and 4, p22phox, p47phox, and gp91phox in peritoneal tissue. Treatment with CG alone was sufficient to cause significant F4/80-positive macrophage infiltration, appearance of α-SMA-positive cells, and vessel formation in the submesothelial layer. Addition of 3,4-DGE markedly enhanced those changes and induced apoptosis, mainly in leukocytes. The concentration of 3,4-DGE in the abdominal cavity declined more rapidly in CG-treated mice than in PBS-treated mice. Peritoneal membrane permeability determined by peritoneal equilibration test showed high transport conditions in peritoneum treated with both CG and 3,4-DGE. These results indicate that, when mild peritoneal damage is already present, 3,4-DGE causes peritoneal thickening and fibrosis, resulting in deterioration of peritoneal membrane function.

[1]  K. Nakao,et al.  Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis. , 2012, Kidney international.

[2]  山本 敬史.  Glutathione depletion as a mechanism of 3,4-dideoxyglucosone-3-ene-induced cytotoxicity in human peritoneal mesothelial cells : role in biocompatibility of peritoneal dialysis fluids , 2012 .

[3]  M. Mizuno,et al.  Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  D. Struijk,et al.  Experimental Peritoneal Sclerosis Models Should Not Be Based on Chlorhexidine Gluconate Anymore , 2010, Nephron Experimental Nephrology.

[5]  H. Chung,et al.  Impact of Low Glucose Degradation Product Bicarbonate/Lactate-Buffered Dialysis Solution on the Epithelial-Mesenchymal Transition of Peritoneum , 2009, American Journal of Nephrology.

[6]  H. Chung,et al.  3,4-Dideoxyglucosone-3-Ene Induces Apoptosis in Human Peritoneal Mesothelial Cells , 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  A. Ortiz,et al.  3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  K. Książek,et al.  Oxidative stress-mediated early senescence contributes to the short replicative life span of human peritoneal mesothelial cells. , 2008, Free radical biology & medicine.

[9]  R. Saxena.  Pathogenesis and treatment of peritoneal membrane failure , 2008, Pediatric Nephrology.

[10]  H. Yokoi,et al.  Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. , 2008, Kidney international.

[11]  K. Książek,et al.  Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose. , 2007, Free radical biology & medicine.

[12]  In‐San Kim,et al.  Effects of Low Glucose Degradation Products Peritoneal Dialysis Fluid on the Peritoneal Fibrosis and Vascularization in a Chronic Rat Model , 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[13]  H. Sugiyama,et al.  Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. , 2007, Kidney International.

[14]  J. Kadota,et al.  Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid , 2007, Journal of Artificial Organs.

[15]  H. Ha,et al.  Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. , 2006, Kidney international.

[16]  M. Zeier,et al.  Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products. , 2005, Journal of the American Society of Nephrology : JASN.

[17]  C. Schalkwijk,et al.  Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  A. Ortiz,et al.  3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis. , 2005, Kidney international.

[19]  M. Lam,et al.  Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  H. Debaix,et al.  Functional and molecular characterization of a peritoneal dialysis model in the C57BL/6J mouse. , 2005, Kidney international.

[21]  N. Lameire,et al.  Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. , 2005, Kidney international.

[22]  Ian R. Drexler,et al.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. , 2005, The Journal of clinical investigation.

[23]  J. West-Mays,et al.  Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. , 2005, Journal of the American Society of Nephrology : JASN.

[24]  H. Vlassara,et al.  Differential expression of receptors for advanced glycation end‐products in peritoneal mesothelial cells exposed to glucose degradation products , 2004, Clinical and experimental immunology.

[25]  T. Nishino,et al.  TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. , 2004, Kidney international.

[26]  P. Gane,et al.  The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  K. Craig,et al.  The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. , 2004, Kidney international.

[28]  J. Jönsson,et al.  PD Fluids Contain High Concentrations of Cytotoxic GDPs Directly after Sterilization , 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[29]  K. Nakao,et al.  Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. , 2004, Journal of the American Society of Nephrology : JASN.

[30]  H. Ha,et al.  Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. , 2004, Kidney international.

[31]  In‐San Kim,et al.  Effect of Glucose Degradation Products on the Peritoneal Membrane in a Chronic Inflammatory Infusion Model of Peritoneal Dialysis in the Rat , 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[32]  K. Wieczorowska-Tobis,et al.  Evidence for Less Irritation to the Peritoneal Membrane in Rats Dialyzed with Solutions Low in Glucose Degradation Products , 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[33]  T. Chan,et al.  Preventing Peritoneal Fibrosis—Insights from the Laboratory , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[34]  S. Meijer,et al.  Single Exposure of Mesothelial Cells to Glucose Degradation Products (GDPs) Yields Early Advanced Glycation End-Products (AGEs) and a Proinflammatory Response , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[35]  A. Yang,et al.  Myofibroblastic conversion of mesothelial cells. , 2003, Kidney international.

[36]  A. Wieslander,et al.  3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis. , 2002, Kidney international.

[37]  R. Tilton,et al.  Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. , 2001, Journal of the American Society of Nephrology : JASN.

[38]  M. Fieren.  Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis. , 1996, Blood purification.

[39]  A. Wieslander,et al.  Heat Sterilization of Fluids for Peritoneal Dialysis Gives Rise to Aldehydes , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.